His main research concerns Surgery, Internal medicine, Oncology, Bladder cancer and Cancer. His Surgery research is multidisciplinary, incorporating elements of Breast cancer, Carcinoma and Hazard ratio. His Internal medicine study focuses mostly on Chemotherapy, Clinical trial, Nephrology, Testicular cancer and Survival analysis.
His work deals with themes such as Cisplatin, Vinblastine, Regimen, Multivariate analysis and Gynecology, which intersect with Oncology. His biological study spans a wide range of topics, including Carcinoma in situ, Urinary bladder, Urology and Cystoscopy. His Cancer study combines topics in areas such as Meta-analysis, Astrocytoma, Glioma and Loading dose.
His primary areas of investigation include Internal medicine, Oncology, Surgery, Urology and Cancer. His study on Internal medicine is mostly dedicated to connecting different topics, such as Gastroenterology. His Oncology research is multidisciplinary, incorporating perspectives in Stage, Combination chemotherapy, Multivariate analysis and Prostate cancer.
His research combines Carcinoma and Surgery. His Urology study integrates concerns from other disciplines, such as Mitomycin C and Epirubicin. Richard Sylvester combines subjects such as Carcinoma in situ and Urinary system with his study of Bladder cancer.
Richard Sylvester mainly investigates Bladder cancer, Urology, Internal medicine, Surgery and Oncology. His Bladder cancer research is multidisciplinary, relying on both Stage, Carcinoma in situ, Nomogram and Intensive care medicine. His Urology research includes themes of Meta-analysis, Proportional hazards model, Nephrectomy, Cystectomy and Urothelial carcinoma.
He has researched Surgery in several fields, including Cancer, Lymphadenectomy and Hazard ratio. He interconnects Toxicity and Confidence interval in the investigation of issues within Cancer. His study in Chemotherapy is interdisciplinary in nature, drawing from both Lung cancer and Carcinoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial
G H J Mickisch;A Garin;H van Poppel;L de Prijck.
The Lancet (2001)
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
GM Mead;SP Stenning;P Cook;SD Fossa.
Journal of Clinical Oncology (1997)
Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial
Joop A. van Dongen;Adri C. Voogd;Ian S. Fentiman;Catherine Legrand.
Journal of the National Cancer Institute (2000)
[Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial].
J.A Van Dongen;A.C Voogd;I.S Fentiman;C Legrand.
Cancer Radiotherapie (2001)
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Marko Babjuk;Maximilian Burger;Richard Zigeuner;Shahrokh F. Shariat.
European Urology (2013)
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
Jean Bourhis;Jens Overgaard;Helene Audry;Kian K. Ang.
The Lancet (2006)
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
JF Tierney;Richard J. Sylvester.
The Lancet (1997)
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma
Francesco Pignatti;Martin van den Bent;Desmond Curran;Channa Debruyne.
Journal of Clinical Oncology (2002)
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
O Dalesio;H van Tinteren;M Clarke;R Peto.
The Lancet (2000)
International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
Gareth Griffiths;Reginald Hall;Richard Sylvester;Derek Raghavan.
Journal of Clinical Oncology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: